Only 51 percent of people in the U.S. who test positive for hepatitis C received the necessary follow- up to determine if they require medical care, according to the Centers for Disease Control and Prevention.
Bristol-Myers Squibb Co., the New York drugmaker that gained 22 percent the past year, said its combination of three experimental medicines for hepatitis C successfully cleared the virus in 15 of 16 patients.
Sanofi, France’s biggest drugmaker, sees revenue growth opportunities from treatments for liver disease in China, home to half the world’s deaths related to the organ, Chief Executive Officer Chris Viehbacher said.
Exxon Mobil Corp. will appeal a $236 million New Hampshire verdict in a case over the use of the gasoline additive MTBE, after having gotten a much larger award in a similar dispute thrown out by a court in Maryland.
Exxon Mobil Corp. should pay New Hampshire $236 million in damages for contaminating its drinking water with the gasoline additive MTBE, the state’s lawyers told a jury that is set to begin deliberations today.